Cleared Traditional

K171769 - Straumann PURE Ceramic Implants

K171769 is an FDA 510(k) clearance for Straumann PURE Ceramic Implants, manufactured by Straumann USA, LLC (On Behalf of Institut Straumann Ag). The device is a Class 2 Dental device with product code DZE cleared through the Traditional 510(k) pathway after a 153-day FDA review.

K171769 · Straumann USA, LLC (On Behalf of Institut Straumann Ag) · Dental device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2017
Decision
153d
Days
Class 2
Risk

K171769 is an FDA 510(k) clearance for the Straumann PURE Ceramic Implants. Classified as Implant, Endosseous, Root-form (product code DZE), Class II - Special Controls.

Submitted by Straumann USA, LLC (On Behalf of Institut Straumann Ag) (Andover, US). The FDA issued a Cleared decision on November 14, 2017 after a review of 153 days - an extended review cycle.

This device falls under the Dental FDA review panel, regulated under 21 CFR 872.3640 - the FDA dental device regulatory framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Dental review framework, consistent with the majority of Class II 510(k) submissions.

View all Straumann USA, LLC (On Behalf of Institut Straumann Ag) devices

FDA 510(k) Submission Details - K171769

510(k) Number K171769 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 14, 2017
Decision Date November 14, 2017
Days to Decision 153 days
Submission Type Traditional
Review Panel Dental (DE)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
26d slower than avg
Panel avg: 127d · This submission: 153d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DZE Device Classification - Class 2, Special Controls

Product Code DZE Implant, Endosseous, Root-form
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 872.3640
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Dental devices follow this clearance model.

Regulatory Consultant

Straumann USA, LLC
Jennifer M. Jackson

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - DZE Implant, Endosseous, Root-form

All 1235
Devices cleared under the same product code (DZE) and FDA review panel - the closest regulatory comparables to K171769.
IR Type Implant System
K171185 · Biotem Co., Ltd. · Dec 2017
BioHorizons Tapered Short Implants
K172576 · BioHorizons Implant Systems, Inc. · Nov 2017
S.I.N. Dental Implant System
K170398 · S.I.N. ? Sistema DE Implante Nacional S.A. · Nov 2017
J2A SLA Dental Implant System
K161923 · Kj Meditech Co., Ltd. · Nov 2017
External Hex Implants
K163634 · Southern Implants (Pty), Ltd. · Nov 2017
TREFOIL System
K172352 · Nobel Biocare AB · Oct 2017